W.L. Gore, Medtronic Lead U.S. Peripheral Vascular Covered Stent Market Due to Higher Patency Rates
According to a new series of reports on the U.S. markets for peripheral vascular devices and accessories by iData Research (www.idataresearch.com), covered stents command a significant price premium over bare-metal stents (BMS). The additional cost is justified by the reduced rates of restenosis offered by covered stents. Because of this advantage, by 2022, the covered stent segment will represent almost 40% of the overall U.S. peripheral stent market. The value of the market for BMS exceeded the value of the...
View full press release